BioCentury | Aug 12, 2019
Company News

Aug. 12 Company Quick Takes: Jazz buying Cavion; plus Boehringer, AC Immune, Oncologie

...frontotemporal lobar degeneration and other neurodegenerative diseases. Oncologie to test lead cancer therapy with Keytruda Oncologie...
...mAb against phosphatidylserine, in combination with Keytruda pembrolizumab in second-line gastric and gastroesophageal cancer patients. Oncologie...
...by Nan Fung Life Sciences and Pivotal bioVenture Partners China (see "$80M Series B Backs Oncologie's...
BioCentury | Jun 10, 2019
Finance

$80M series B backs Oncologie's biomarkers, which could give new life to old therapies

...in the cancer company's tranched $80 million series B. The funds are expected to push Oncologie...
...an additional in-licensing deal, look for the company to round out its pipeline this year. Oncologie...
...to $27.5 million, Oncologie President and CEO Laura Benjamin told BioCentury. In the year since, Oncologie...
BioCentury | Aug 31, 2018
Company News

Oncologie, Mologen negotiating larger lefitolimod deal

...Mologen AG (Xetra:MGNK) and Oncologie Inc. (Cayman Islands) agreed on Aug. 17 to a three month...
...a deal granting Oncologie exclusive, worldwide rights to Mologen's lead compound lefitolimod (MGN1703). In February, Oncologie...
...cancer (SCLC). Mologen AG (Xetra:MGNK), Berlin, Germany Oncologie Inc., Cayman Islands Business: Cancer Shannon Lehnbeuter lefitolimod (MGN1703) Mologen AG Oncologie...
BioCentury | Aug 10, 2018
Company News

HTG, Oncologie partner to develop biomarkers

...partnered to develop biomarkers associated with Oncologie's immuno-oncology pipeline. The partners declined to disclose details. Oncologie...
...Molecular Diagnostics Inc. (NASDAQ:HTGM), Tuscon, Ariz. Oncologie Inc., Waltham, Mass. Business: Diagnostic Shannon Lehnbeuter HTG Molecular Diagnostics Inc. Oncologie...
BioCentury | Jun 8, 2018
Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

...Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal...
...the round. Oncologie plans to develop in-licensed cancer assets in China and the U.S. simultaneously. Oncologie...
...p=0.006). Oncologie Ltd., Cayman Islands Jaime De Leon bavituximab (3G4, Tarvacin) lefitolimod (MGN1703) Avid Bioservices Inc. Mologen AG Phosphatidylserine Toll-like receptor 9 (TLR9) Oncologie...
BioCentury | Jun 7, 2018
Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

...Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal...
...the round. Oncologie plans to develop in-licensed cancer assets in China and the U.S. simultaneously. Oncologie...
...to treat advanced solid malignancies in combination with anti-CTLA-4 mAb Yervoy ipilimumab. Early next year, Oncologie...
BioCentury | Feb 23, 2018
Company News

Oncologie gains rights to Mologen's lefitolimod

...Mologen AG (Xetra:MGN) granted Oncologie Ltd. (Cayman Islands) exclusive, global co-development rights and rights to develop...
...Mologen said the co-development portion of the deal will include leverage "novel biomarker plans from Oncologie."...
...lung cancer (SCLC). Mologen AG (Xetra:MGN), Berlin, Germany Oncologie Ltd., Cayman Islands Business: Cancer Shannon Lehnbeuter lefitolimod Mologen AG Oncologie...
BioCentury | Feb 16, 2018
Company News

Oncologie purchases bavituximab from Avid

...for $95 million in development, regulatory and commercialization milestones. Avid is also eligible for royalties. Oncologie...
...Avid Bioservices Inc. (NASDAQ:CDMO) Tustin, Calif. Oncologie Ltd., Cayman Islands Business: Cancer Shannon Lehnbeuter Avid Bioservices Inc. Oncologie...
BioCentury | Mar 19, 2016
Company News

Management tracks

...and John Felitti general counsel. Brandely was director of clinical development at the Pierre Fabre Oncologie...
BioCentury | Aug 7, 2001
Company News

Baxter to acquire Asta Medica Oncologie

...acquire Degussa subsidiary Asta Medica Oncologie (Frankfurt, Germany) for EUR525 million ($470 million). Asta Medica Oncologie...
Items per page:
1 - 10 of 12
BioCentury | Aug 12, 2019
Company News

Aug. 12 Company Quick Takes: Jazz buying Cavion; plus Boehringer, AC Immune, Oncologie

...frontotemporal lobar degeneration and other neurodegenerative diseases. Oncologie to test lead cancer therapy with Keytruda Oncologie...
...mAb against phosphatidylserine, in combination with Keytruda pembrolizumab in second-line gastric and gastroesophageal cancer patients. Oncologie...
...by Nan Fung Life Sciences and Pivotal bioVenture Partners China (see "$80M Series B Backs Oncologie's...
BioCentury | Jun 10, 2019
Finance

$80M series B backs Oncologie's biomarkers, which could give new life to old therapies

...in the cancer company's tranched $80 million series B. The funds are expected to push Oncologie...
...an additional in-licensing deal, look for the company to round out its pipeline this year. Oncologie...
...to $27.5 million, Oncologie President and CEO Laura Benjamin told BioCentury. In the year since, Oncologie...
BioCentury | Aug 31, 2018
Company News

Oncologie, Mologen negotiating larger lefitolimod deal

...Mologen AG (Xetra:MGNK) and Oncologie Inc. (Cayman Islands) agreed on Aug. 17 to a three month...
...a deal granting Oncologie exclusive, worldwide rights to Mologen's lead compound lefitolimod (MGN1703). In February, Oncologie...
...cancer (SCLC). Mologen AG (Xetra:MGNK), Berlin, Germany Oncologie Inc., Cayman Islands Business: Cancer Shannon Lehnbeuter lefitolimod (MGN1703) Mologen AG Oncologie...
BioCentury | Aug 10, 2018
Company News

HTG, Oncologie partner to develop biomarkers

...partnered to develop biomarkers associated with Oncologie's immuno-oncology pipeline. The partners declined to disclose details. Oncologie...
...Molecular Diagnostics Inc. (NASDAQ:HTGM), Tuscon, Ariz. Oncologie Inc., Waltham, Mass. Business: Diagnostic Shannon Lehnbeuter HTG Molecular Diagnostics Inc. Oncologie...
BioCentury | Jun 8, 2018
Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

...Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal...
...the round. Oncologie plans to develop in-licensed cancer assets in China and the U.S. simultaneously. Oncologie...
...p=0.006). Oncologie Ltd., Cayman Islands Jaime De Leon bavituximab (3G4, Tarvacin) lefitolimod (MGN1703) Avid Bioservices Inc. Mologen AG Phosphatidylserine Toll-like receptor 9 (TLR9) Oncologie...
BioCentury | Jun 7, 2018
Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

...Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal...
...the round. Oncologie plans to develop in-licensed cancer assets in China and the U.S. simultaneously. Oncologie...
...to treat advanced solid malignancies in combination with anti-CTLA-4 mAb Yervoy ipilimumab. Early next year, Oncologie...
BioCentury | Feb 23, 2018
Company News

Oncologie gains rights to Mologen's lefitolimod

...Mologen AG (Xetra:MGN) granted Oncologie Ltd. (Cayman Islands) exclusive, global co-development rights and rights to develop...
...Mologen said the co-development portion of the deal will include leverage "novel biomarker plans from Oncologie."...
...lung cancer (SCLC). Mologen AG (Xetra:MGN), Berlin, Germany Oncologie Ltd., Cayman Islands Business: Cancer Shannon Lehnbeuter lefitolimod Mologen AG Oncologie...
BioCentury | Feb 16, 2018
Company News

Oncologie purchases bavituximab from Avid

...for $95 million in development, regulatory and commercialization milestones. Avid is also eligible for royalties. Oncologie...
...Avid Bioservices Inc. (NASDAQ:CDMO) Tustin, Calif. Oncologie Ltd., Cayman Islands Business: Cancer Shannon Lehnbeuter Avid Bioservices Inc. Oncologie...
BioCentury | Mar 19, 2016
Company News

Management tracks

...and John Felitti general counsel. Brandely was director of clinical development at the Pierre Fabre Oncologie...
BioCentury | Aug 7, 2001
Company News

Baxter to acquire Asta Medica Oncologie

...acquire Degussa subsidiary Asta Medica Oncologie (Frankfurt, Germany) for EUR525 million ($470 million). Asta Medica Oncologie...
Items per page:
1 - 10 of 12